DMCC Speciality Chemicals revenue up 35% in FY26 on higher realisations

3 min read     Updated on 18 Aug 2026, 05:01 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

DMCC Speciality Chemicals reported FY26 revenue of ₹581.58 crore, up 34.84% YoY, driven by higher sulphur prices in the bulk chemicals segment. PAT rose 26.95% to ₹27.33 crore, though EBITDA margins contracted to 11.04% from 13.49%. The Board proposed a ₹2.50 per share dividend and seeks approval to raise borrowing limits to ₹400 crore.

powered bylight_fuzz_icon
48597925

*this image is generated using AI for illustrative purposes only.

DMCC Speciality Chemicals reported consolidated revenue from operations of ₹581.58 crore for the financial year ended March 31, 2026 (FY26), marking a 34.84% increase over FY25. The growth was primarily driven by higher realisations in the bulk chemicals segment, where sustained rises in sulphur prices translated into elevated sulphuric acid pricing.

Profit after tax (PAT) rose 26.95% to ₹27.33 crore from ₹21.54 crore in the prior year. EBITDA increased by 10.23% to ₹64.33 crore. However, the consolidated EBITDA margin moderated to 11.04% from 13.49% in FY25, as the higher revenue base created by elevated commodity prices diluted percentage margins even as absolute profitability was protected.

Financial Performance

The company’s financial results reflect resilience amid global supply chain disruptions and geopolitical tensions affecting raw material availability.

Metric: FY26 FY25 Change
Revenue from Operations: ₹581.58 crore ₹431.29 crore +34.84%
EBITDA: ₹64.33 crore ₹58.34 crore +10.23%
EBITDA Margin: 11.04% 13.49% -245 bps
Profit After Tax: ₹27.33 crore ₹21.54 crore +26.95%

Interest costs declined by 8.48% to ₹9.61 crore, although short-term borrowings rose in the second half of the year to fund higher working capital requirements.

Segment Review

The bulk chemicals segment was the principal driver of revenue growth, supported almost entirely by domestic demand. Tight global sulphur availability, compounded by disruptions to shipments through the Strait of Hormuz, drove prices to elevated levels. The company passed these higher input costs through to customers, protecting absolute profitability. Volumes held broadly steady, with the Dahej facility operating at normal levels while the Roha site faced temporary raw material constraints towards year-end.

In speciality chemicals, subdued demand in traditional European markets continued. The company expanded its presence in alternative geographies, recording improved offtake in Latin America, China, Japan, and Korea. Capacity utilisation in this segment continues to carry headroom, providing scope for scale-up as demand recovers.

The boron chemicals business experienced an uneven year due to a disruption in boron ore supply from Turkey in the first half. Supply was restored in the second half, allowing plants to run at full capacity with inventory rebuilt. Changes in procurement terms to advance payments added to the segment’s working capital requirement.

Dividend and AGM Details

The Board of Directors has recommended a final dividend of ₹2.50 per equity share of face value ₹10 each for FY26. This represents a 25% dividend yield on the face value. The record date for determining dividend eligibility is August 21, 2026. Payment will be made within 30 days of approval at the Annual General Meeting (AGM).

The 105th AGM is scheduled for September 11, 2026, to be conducted through Video Conferencing or Other Audio Visual Means (VC/OAVM). Key resolutions include:

  • Adoption of audited standalone and consolidated financial statements for FY26.
  • Reappointment of Mr. Kuldeep Tiwari as a director upon retirement by rotation.
  • Ratification of remuneration of ₹1,00,000 plus taxes and expenses for S. S. Dongare as cost auditor for FY27.
  • Approval for payment of commission to non-executive directors, capped at 1% of net profits computed under Section 198 of the Companies Act, 2013, for three years starting from FY27.

Borrowing Limit Enhancement

Shareholders will consider a special resolution to enhance borrowing powers from ₹200 crore to ₹400 crore. This authority allows the board to borrow funds exceeding the aggregate of paid-up share capital and free reserves for working capital requirements, acquisition of capital assets, and other corporate needs. Concurrently, shareholders will approve the creation of mortgages and charges on movable and immovable properties to secure these loans up to the same limit.

What the Numbers Show

The divergence between top-line growth and margin compression highlights the commodity-driven nature of DMCC’s current earnings profile. While revenue surged nearly 35%, EBITDA grew only 10%, indicating that volume growth was minimal and gains were purely price-led. Furthermore, the rise in short-term borrowings alongside stable interest costs suggests efficient debt management, but the increasing working capital requirement in the boron segment signals potential liquidity pressure if procurement terms remain unchanged.

Historical Stock Returns for DMCC Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-2.01%-8.10%+8.48%+20.37%-12.87%-5.95%

How sustainable is the current pricing power for sulphuric acid if global sulphur supply chains normalize post-Strait of Hormuz disruptions?

Will the doubling of borrowing limits to ₹400 crore signal specific upcoming capital expenditures or acquisitions in the specialty chemicals segment?

Can DMCC leverage its excess capacity in specialty chemicals to offset continued demand weakness in European markets with faster growth in Asia and Latin America?

DMCC Speciality Chemicals
View Company Insights
View All News
like17
dislike

DMCC Speciality Chemicals Q1FY27 PAT up 163% to ₹20.40 Cr on price surge

3 min read     Updated on 13 Aug 2026, 01:44 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

DMCC Speciality Chemicals posted a 163% YoY jump in Q1FY27 PAT to ₹20.40 crore, driven by surging sulphur prices and inventory gains. Revenue nearly doubled to ₹253.01 crore, with EBITDA margin expanding slightly to 13.59%. Management warned that profits include non-recurring inventory gains that will reverse as prices normalize, while working capital pressure increased due to higher receivables and inventory levels.

powered bylight_fuzz_icon
47986400

*this image is generated using AI for illustrative purposes only.

DMCC Speciality Chemicals Limited reported a substantial improvement in its financial performance for the quarter ended June 30, 2026 (Q1FY27), with consolidated net profit after tax rising 163.11% year-on-year to ₹20.40 crore. Revenue from operations more than doubled to ₹253.01 crore, up 99.15% from ₹127.04 crore in the corresponding quarter of the previous year. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on August 10, 2026, and have been prepared in accordance with Indian Accounting Standards (Ind AS).

Consolidated Financial Performance

The company’s consolidated results reflect strong top-line growth and improved profitability metrics. EBITDA increased 99.58% year-on-year to ₹34.43 crore, with the EBITDA margin expanding by 5 basis points to 13.59%. This compares to an EBITDA of ₹17.25 crore and a margin of 13.54% in Q1FY26. Profit before tax stood at ₹27.21 crore, compared to ₹11.03 crore in the prior year period.

The following table presents the consolidated financial highlights:

Metric: Q1 FY27 (30.06.2026) Unaudited Q4 FY26 (31.03.2026) Audited Q1 FY26 (30.06.2025) Unaudited FY26 Year Ended (31.03.2026)
Total Income from Operations (₹ Crore): 253.31 177.80 127.42 582.61
EBITDA (₹ Crore): 34.43 17.86 17.25
EBITDA Margin (%): 13.59 10.05 13.54
Net Profit before Tax (₹ Crore): 27.21 10.81 11.03 38.96
Net Profit after Tax (₹ Crore): 20.40 7.65 7.76 27.33
Basic & Diluted EPS (₹): 8.18 3.07 3.11 10.96

On a standalone basis, total income from operations rose to ₹253.29 crore from ₹127.30 crore in Q1FY26. Standalone net profit after tax was ₹20.41 crore, compared to ₹7.75 crore in the year-ago quarter.

Operational Highlights and Management Commentary

Bimal Goculdas, Managing Director and CEO, attributed the sharp growth in revenue and profitability to a significant escalation in sulphur and sulfuric acid prices. He noted that a meaningful portion of the reported profitability reflects inventory gains, which will reverse as prices moderate, leading to normalised profits. "I would urge shareholders to read these numbers with that lens," Goculdas said.

The pricing environment also impacted working capital, with receivables and inventory balances growing materially. The company is managing this through short-term borrowings. Despite supply disruptions affecting approximately 50% of global sulphur trade transiting the Strait of Hormuz, DMCC’s Dahej and Roha facilities operated without interruption. The company passed on cost increases fully without losing volumes.

In the boron segment, demand, pricing, and supply all improved, meeting quarterly targets. For speciality chemicals, exports to Latin America, China, and Japan compensated for a subdued European market, supporting geographic diversification efforts.

Segment and Geographic Mix

The company operates in a single segment—manufacturing and sale of chemicals—and therefore segment-wise disclosure requirements under Ind AS 108 are not applicable. However, management disclosed the following revenue mix for Q1FY27:

  • Domestic Revenues: 90%
  • Export Revenues: 10%
  • Bulk Chemicals Sales: 76%
  • Speciality Chemicals Sales: 24%

Key Notes and Disclosures

Several notable disclosures accompanied the quarterly results:

  • The statutory auditors conducted a limited review of the financial results for the quarter ended June 30, 2026 and issued an unmodified review opinion.
  • The figures for the quarter ended March 31, 2026 represent balancing figures between the audited full-year figures and the unaudited nine-month figures ended December 31, 2025.
  • The full format of the financial results is available on the websites of BSE Limited, the National Stock Exchange of India Ltd., and the company's website.

The results were signed off by Bimal Latesh Goudsal, Managing Director & Chief Executive Officer (DIN: 00242783), at Mumbai on August 10, 2026.

Historical Stock Returns for DMCC Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-2.01%-8.10%+8.48%+20.37%-12.87%-5.95%

How will the anticipated reversal of inventory gains impact DMCC's net profit margins in Q2FY27 as sulphur prices moderate?

What specific strategies is management implementing to mitigate the rising working capital requirements driven by increased receivables and inventory levels?

Could the current supply disruptions in the Strait of Hormuz lead to sustained pricing power for sulphur and sulfuric acid beyond the short term?

DMCC Speciality Chemicals
View Company Insights
View All News
like20
dislike

More News on DMCC Speciality Chemicals

1 Year Returns:-12.87%